The real-world effectiveness and safety of vedolizumab for moderate–severe Crohn’s disease: Results from the US VICTORY consortium

The American Journal of Gastroenterology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/1Q3JwUz
via IFTTT